Docetaxel 20 mg/mL

Docetaxel 20 mg/mL is an injectable solution used for various medical treatments. This single-dose vial is manufactured by Hospira, Inc. in the USA, and is administered intravenously.

Docetaxel 20 mg/mL is primarily used in the treatment of certain types of cancer. It is often prescribed for advanced or metastatic breast cancer, non-small cell lung cancer, and other solid tumors. The medication works by interfering with the growth and spread of cancer cells. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Common effects of Docetaxel 20 mg/mL may include fatigue, nausea, and hair loss. Some patients may experience a decrease in blood cell counts, which can lead to increased risk of infection or bleeding. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Docetaxel 20 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper administration procedures to avoid contamination or accidental exposure. Patients should be aware of potential allergic reactions and inform their healthcare provider of any known allergies. Pregnant women or those planning to become pregnant should discuss the risks with their doctor.

Docetaxel 20 mg/mL may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the efficacy of the medication.